e-learning
resources
Barcelona 2013
Saturday, 07.09.2013
PG20 Cystic fibrosis: an update of the basic defects and clinical problems in CF children and adults
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Early CF lung disease- how to detect, to treat and follow up
C. Robertson (Victoria, Australia)
Source:
Annual Congress 2013 –PG20 Cystic fibrosis: an update of the basic defects and clinical problems in CF children and adults
Session:
PG20 Cystic fibrosis: an update of the basic defects and clinical problems in CF children and adults
Session type:
Postgraduate Course
Number:
66
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Robertson (Victoria, Australia). Early CF lung disease- how to detect, to treat and follow up. Annual Congress 2013 –PG20 Cystic fibrosis: an update of the basic defects and clinical problems in CF children and adults
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
How to manage a patient with COPD - early identification and how to prevent progression
Source: ERS Satellites 2021
Year: 2021
Biometric monitoring in silicosis to detect early disease and monitor lung injury: not quite there
Source: ERJ Open Res, 2 (4) 00093-2016; 10.1183/23120541.00093-2016
Year: 2016
Biometric monitoring in silicosis to detect early disease and monitor lung injury: not quite there
Source: ERJ Open Res, 2 (4) 00086-2016; 10.1183/23120541.00086-2016
Year: 2016
Monitoring of early lung disease. To know is to treat!
Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early
Year: 2004
How to better assess and predict disease progression and treatment response: home-based spirometry, biomarkers or …?
Source: International Congress 2019 – High-tech in interstitial lung diseases: just hype and gadgets?
Year: 2019
Does the lung clearance index track with disease progression in early childhood?
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015
Identifying serum molecular biomarkers that distinguish emphysema and early fibrotic interstitial lung disease.
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
Monitoring of early lung disease: Is it clinically important to do routine infant lung function test?
Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early
Year: 2004
In whom could we diagnose second primary lung cancers ‘early’?
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019
Occupational COPD : what is new and how do we identify and ultimately prevent this disease?
Source: International Congress 2019 – PG13 Traditional and modern clinical approaches for diagnosis and management of occupational airways diseases
Year: 2019
Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients?
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review
Source: ERJ Open Res, 7 (4) 00441-2021; 10.1183/23120541.00441-2021
Year: 2021
Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation?
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
Domiciliary monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and/or progression: a systematic review
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Early interventions with bacterial metabolites to prevent the development of chronic lung diseases
Source: International Congress 2018 – Cross-talk in the lung microenvironment: implications for chronic lung disease
Year: 2018
Poor performance status patient in advanced lung cancer: to treat or not to treat?
Source: Annual Congress 2008 - MP13 - Poor performance status patient in advanced lung cancer: to treat or not to treat?
Year: 2008
The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 327s
Year: 2006
Nurse led lung cancer diagnostic/supportive follow up clinic;a different approach to optimise lung cancer pathway
Source: International Congress 2018 – The many facets of respiratory nursing
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept